Deepak Nitrite Ltd
Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine 
& Speciality Chemicals, Performance 
Products, and Phenolics[1]
- Market Cap ₹ 23,567 Cr.
- Current Price ₹ 1,728
- High / Low ₹ 2,908 / 1,725
- Stock P/E 96.7
- Book Value ₹ 229
- Dividend Yield 0.43 %
- ROCE 10.1 %
- ROE 8.22 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 27.5%
Cons
- Stock is trading at 7.54 times its book value
- The company has delivered a poor sales growth of 2.53% over past five years.
- Company has a low return on equity of 12.9% over last 3 years.
- Earnings include an other income of Rs.144 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE MidCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,270 | 1,327 | 1,336 | 1,233 | 1,455 | 1,792 | 2,230 | 1,809 | 2,511 | 3,034 | 2,724 | 2,526 | 2,423 | |
| 1,154 | 1,186 | 1,166 | 1,086 | 1,245 | 1,480 | 1,425 | 1,271 | 1,865 | 2,446 | 2,278 | 2,233 | 2,169 | |
| Operating Profit | 116 | 141 | 170 | 146 | 210 | 312 | 805 | 538 | 646 | 588 | 446 | 294 | 254 | 
| OPM % | 9% | 11% | 13% | 12% | 14% | 17% | 36% | 30% | 26% | 19% | 16% | 12% | 10% | 
| -0 | 1 | -0 | 83 | 6 | -2 | 1 | 13 | 71 | 101 | 203 | 149 | 144 | |
| Interest | 28 | 38 | 39 | 32 | 42 | 45 | 22 | 6 | 3 | 3 | 4 | 5 | 4 | 
| Depreciation | 30 | 36 | 39 | 48 | 52 | 53 | 78 | 67 | 73 | 76 | 87 | 100 | 101 | 
| Profit before tax | 58 | 68 | 91 | 149 | 122 | 212 | 706 | 479 | 642 | 610 | 558 | 338 | 293 | 
| Tax % | 34% | 21% | 29% | 26% | 32% | 35% | 23% | 26% | 24% | 23% | 22% | 18% | |
| 38 | 53 | 65 | 111 | 83 | 138 | 544 | 355 | 486 | 469 | 433 | 276 | 244 | |
| EPS in Rs | 3.67 | 5.11 | 5.60 | 8.46 | 6.12 | 10.12 | 39.89 | 26.01 | 35.65 | 34.41 | 31.78 | 20.27 | 17.86 | 
| Dividend Payout % | 27% | 20% | 21% | 14% | 21% | 20% | 11% | 21% | 20% | 22% | 24% | 37% | 
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% | 
| 5 Years: | 3% | 
| 3 Years: | 0% | 
| TTM: | -11% | 
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% | 
| 5 Years: | -15% | 
| 3 Years: | -20% | 
| TTM: | -31% | 
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% | 
| 5 Years: | 18% | 
| 3 Years: | -9% | 
| 1 Year: | -34% | 
| Return on Equity | |
|---|---|
| 10 Years: | 17% | 
| 5 Years: | 16% | 
| 3 Years: | 13% | 
| Last Year: | 8% | 
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 
| Reserves | 297 | 326 | 453 | 706 | 917 | 1,031 | 1,464 | 1,817 | 2,229 | 2,598 | 2,927 | 3,099 | 
| 508 | 545 | 495 | 574 | 462 | 328 | 219 | 8 | 24 | 11 | 32 | 50 | |
| 245 | 234 | 290 | 254 | 397 | 450 | 344 | 324 | 364 | 415 | 385 | 444 | |
| Total Liabilities | 1,061 | 1,126 | 1,261 | 1,559 | 1,802 | 1,835 | 2,054 | 2,177 | 2,644 | 3,050 | 3,372 | 3,620 | 
| 461 | 549 | 593 | 568 | 569 | 589 | 720 | 776 | 674 | 728 | 835 | 898 | |
| CWIP | 71 | 38 | 14 | 41 | 36 | 29 | 90 | 69 | 83 | 77 | 126 | 170 | 
| Investments | 3 | 17 | 133 | 358 | 455 | 563 | 563 | 689 | 909 | 1,057 | 945 | 1,372 | 
| 526 | 522 | 520 | 593 | 742 | 654 | 682 | 644 | 978 | 1,188 | 1,466 | 1,179 | |
| Total Assets | 1,061 | 1,126 | 1,261 | 1,559 | 1,802 | 1,835 | 2,054 | 2,177 | 2,644 | 3,050 | 3,372 | 3,620 | 
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | 105 | 191 | 93 | 214 | 277 | 515 | 442 | 228 | 310 | 418 | 254 | |
| -97 | -87 | -162 | -274 | -189 | -78 | -268 | -226 | -159 | -188 | -156 | -333 | |
| 108 | -22 | -28 | 178 | -25 | -198 | -248 | -215 | -64 | -113 | -106 | -88 | |
| Net Cash Flow | -3 | -4 | 1 | -2 | -0 | 2 | -1 | 1 | 4 | 9 | 157 | -167 | 
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 84 | 86 | 81 | 93 | 93 | 70 | 60 | 71 | 80 | 72 | 82 | 89 | 
| Inventory Days | 60 | 47 | 57 | 76 | 85 | 92 | 102 | 106 | 105 | 100 | 96 | 121 | 
| Days Payable | 63 | 48 | 60 | 93 | 140 | 125 | 102 | 108 | 80 | 64 | 60 | 79 | 
| Cash Conversion Cycle | 81 | 85 | 78 | 76 | 37 | 38 | 61 | 70 | 105 | 108 | 118 | 131 | 
| Working Capital Days | 17 | -2 | -23 | -20 | -3 | 56 | 62 | 75 | 94 | 97 | 130 | 112 | 
| ROCE % | 12% | 12% | 14% | 9% | 12% | 19% | 47% | 27% | 31% | 24% | 16% | 10% | 
Documents
Announcements
- 
        
          Board Meeting Intimation for Consider And Approve The Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2025.
          
            28 Oct - Board meeting on 12 Nov 2025 to approve unaudited Q2/H1 results ended 30 Sep 2025.
- 
        
          Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
          
            17 Oct - DCTL allotted 40,00,000 9% OCRPS (₹40.00 crore) to sister subsidiary DPL on Oct 17, 2025.
- 
        
          Disclosure Under Regulation 30 Of SEBI (LODR), Regulations, 2015
          
            9 Oct - GST order dated Oct 8, 2025: recovery and penalty INR 2,15,34,798 against Deepak Phenotics (DPL).
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Oct
- 
        
          Press Release
          
            6 Oct - Inauguration of 5-acre DRDC 2.0 R&D centre at Savli, Vadodara on 06 Oct 2025.
Annual reports
- 
    
      Financial Year 2025
      from bse
- 
    
      Financial Year 2024
      from bse
- 
    
      Financial Year 2023
      from bse
- 
    
      Financial Year 2022
      from bse
- 
    
      Financial Year 2021
      from bse
- 
    
      Financial Year 2020
      from bse
- 
    
      Financial Year 2019
      from bse
- 
    
      Financial Year 2018
      from bse
- 
    
      Financial Year 2017
      from bse
- 
    
      Financial Year 2016
      from bse
- 
    
      Financial Year 2015
      from bse
- 
    
      Financial Year 2014
      from bse
- 
    
      Financial Year 2013
      from bse
- 
    
      Financial Year 2012
      from bse
- 
    
      Financial Year 2012
      from nse
Concalls
- 
      Aug 2025Transcript PPT
- 
      Jun 2025Transcript PPT
- 
      Feb 2025Transcript PPT
- 
      Nov 2024Transcript PPT REC
- 
      Aug 2024Transcript PPT
- 
      May 2024Transcript PPT REC
- 
      Feb 2024Transcript PPT REC
- 
      Nov 2023Transcript PPT
- 
      Aug 2023Transcript PPT
- 
      Aug 2023TranscriptNotesPPT
- 
      May 2023Transcript PPT REC
- 
      May 2023TranscriptNotesPPT
- 
      Feb 2023Transcript PPT
- 
      Nov 2022TranscriptPPT
- 
      Aug 2022Transcript PPT
- 
      May 2022TranscriptPPT
- 
      Jan 2022TranscriptPPT
- 
      Oct 2021TranscriptPPT
- 
      Aug 2021TranscriptPPT
- 
      May 2021TranscriptPPT
- 
      Feb 2021Transcript PPT
- 
      Oct 2020TranscriptNotesPPT
- 
      Aug 2020TranscriptNotesPPT
- 
      May 2020TranscriptNotesPPT
- 
      Feb 2020TranscriptNotesPPT
- 
      Oct 2019TranscriptNotesPPT
- 
      Aug 2019TranscriptNotesPPT
- 
      May 2019TranscriptNotesPPT
- 
      Feb 2019TranscriptNotesPPT
- 
      Oct 2018TranscriptNotesPPT
- 
      Aug 2018TranscriptNotesPPT
- 
      May 2018TranscriptNotesPPT
- 
      Jan 2018TranscriptNotesPPT
- 
      Nov 2017TranscriptNotesPPT
- 
      Aug 2017TranscriptNotesPPT
- 
      Feb 2017TranscriptNotesPPT
Business Segments
The company is one of the fastest growing chemical intermediates company in India with a portfolio of 32+ products and 56+ applications, divided into 2 segments: [1]